Capital raised by Beacon Biosignals
1 Form D filing · first filed Oct 2025 · Boston, MA
Chief Executive Officer
Signatory on Beacon Biosignals's Form D filings · $103.3M raised across 1
Jacob A. Donoghue, M.D., Ph.D. is on file as Chief Executive Officer at Beacon Biosignals in Boston, MA. Beacon Biosignals has 1 Form D filing on record, $103.3M raised in total. Jacob A. Donoghue, M.D., Ph.D. appears as a signatory on the company's filings.
A precision-medicine platform for collecting, integrating, and analyzing EEG data across the drug development lifecycle, from trial design through biomarker discovery and patient stratification.
